Scout | ExTReMe: Funding to Translate Extracellular Vesicle (EV) Therapies for Regenerative Medicine

forecast

ExTReMe: Funding to Translate Extracellular Vesicle (EV) Therapies for Regenerative Medicine

NCATS is supporting research to translate extracellular vesicle (EV)–based therapeutics for regenerative medicine. The program focuses on advancing EV approaches such as off-the-shelf stem cell–derived EV therapies produced under GLP conditions, as well as engineered or designer EVs tailored to patient needs. Projects should help move EV treatments toward clinical application in tissue repair …

Source

Agency: National Institutes of Health

Eligibility

government

individual

industry:research

nonprofit

small_business

tribal

university

For profit organizations other than small businesses

Native American tribal governments (Federally recognized)

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Private institutions of higher education

State governments

Keywords

extracellular vesicles

ev therapeutics

regenerative medicine

exosomes

glp production

designer evs

cell-free therapy

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers